These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 30242192

  • 21. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
    Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP.
    Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
    [Abstract] [Full Text] [Related]

  • 22. Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA2DS2-VASc score in three cross-sectional studies.
    Cordts K, Grzybowski R, Lezius S, Lüneburg N, Atzler D, Neu A, Hornig S, Böger RH, Gerloff C, Magnus T, Thomalla G, Schwedhelm E, Grant PJ, Choe CU.
    J Neurol Sci; 2019 Feb 15; 397():156-161. PubMed ID: 30640152
    [Abstract] [Full Text] [Related]

  • 23. Arginine derivatives in atrial fibrillation progression phenotypes.
    Büttner P, Bahls M, Böger RH, Hindricks G, Thiele H, Schwedhelm E, Kornej J.
    J Mol Med (Berl); 2020 Jul 15; 98(7):999-1008. PubMed ID: 32504111
    [Abstract] [Full Text] [Related]

  • 24. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.
    Clin Res Cardiol; 2018 Mar 15; 107(3):201-213. PubMed ID: 29101459
    [Abstract] [Full Text] [Related]

  • 25. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
    Böger RH, Endres HG, Schwedhelm E, Darius H, Atzler D, Lüneburg N, von Stritzky B, Maas R, Thiem U, Benndorf RA, Diehm C.
    J Intern Med; 2011 Mar 15; 269(3):349-61. PubMed ID: 21175900
    [Abstract] [Full Text] [Related]

  • 26. Assessment of asymmetrical dimethylarginine metabolism in patients with critical illness.
    Ghashut RA, Blackwell S, Ryan S, Willox L, McMillan DC, Kinsella J, Talwar D.
    Eur J Clin Invest; 2017 Apr 15; 47(4):279-288. PubMed ID: 27930821
    [Abstract] [Full Text] [Related]

  • 27. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
    Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, März W.
    Clin Chem; 2011 Jan 15; 57(1):112-21. PubMed ID: 21036946
    [Abstract] [Full Text] [Related]

  • 28. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH.
    Atherosclerosis; 2010 Feb 15; 208(2):518-23. PubMed ID: 19700158
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Lung; 2017 Dec 15; 195(6):717-727. PubMed ID: 28852826
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Toxic Dimethylarginines: Asymmetric  Dimethylarginine (ADMA) and Symmetric  Dimethylarginine (SDMA).
    Tain YL, Hsu CN.
    Toxins (Basel); 2017 Mar 06; 9(3):. PubMed ID: 28272322
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.